Lidonexe
NDC Package 69329-002-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lidonexe is clean and dry affected area.Remove patch from backing and apply to affected area.Use only one patch at a time, and maximum of four patches/day.Leave patch on affected area for up to 8-hours.Do not use patches for longer than five consecutive days.Children under 12 should consult physician prior to use. Marketed by Patchwerx Labs, Inc., this product is identified by NDC 69329-002 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
69329-002-25
Package Description
25 PATCH in 1 BOX / 10 g in 1 PATCH
Product Code
69329-002
11-Digit Billing Format
69329000225
RxNorm Crosswalk
  • RxCUI: 1373130 - lidocaine HCl 4 % / menthol 1 % Medicated Patch
  • RxCUI: 1373130 - lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Medicated Patch

Clinical Specifications

Proprietary Name
Lidonexe
Dosage Form
-
Usage Information
Clean and dry affected area.Remove patch from backing and apply to affected area.Use only one patch at a time, and maximum of four patches/day.Leave patch on affected area for up to 8-hours.Do not use patches for longer than five consecutive days.Children under 12 should consult physician prior to use.

Regulatory & Marketing

Labeler Name
Patchwerx Labs, Inc.
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
11-10-2014
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69329-002). Click a package code to view its specific billing and regulatory data.

69329-002-05
5 PATCH in 1 BOX / 10 g in 1 PATCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69329-002-25 identifies a specific commercial package of 25 patch in 1 box / 10 g in 1 patch of Lidonexe, labeled by Patchwerx Labs, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Patchwerx Labs, Inc. on November 10, 2014. The current certification is valid through December 31, 2017.

How is this Patchwerx Labs, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69329000225. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69329-002-25
11-Digit CMS (5-4-2)
69329-0002-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.